Cited by 99Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCognitive Abilities and Testing

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease

Open access
Honea, Robyn A., Swerdlow, Russell H., Vidoni, Eric D., Burns, Jeffrey M.·2011·Neurology

Abstract

OBJECTIVE: Beyond age, having a family history is the most significant risk factor for Alzheimer disease (AD). This longitudinal brain imaging study examines whether there are differential patterns of regional gray matter atrophy in cognitively healthy elderly subjects with (FH+) and without (FH-) a family history of late-onset AD. METHODS: As part of the KU Brain Aging Project, cognitively intact individuals with a maternal history (FHm, n = 11), paternal history (FHp, n = 10), or no parental history of AD (FH-, n = 32) similar in age, gender, education, and Mini-Mental State Examination (MMSE) score received MRI at baseline and 2-year follow-up. A custom voxel-based morphometry processing stream was used to examine regional differences in atrophy between FH groups, controlling for age, gender, and APOE ε4 (APOE4) status. We also analyzed APOE4-related atrophy. RESULTS: Cognitively normal FH+ individuals had significantly increased whole-brain gray matter atrophy and CSF expansion compared to FH-. When FH+ groups were split, only FHm was associated with longitudinal measures of brain change. Moreover, our voxel-based analysis revealed that FHm subjects had significantly greater atrophy in the precuneus and parahippocampus/hippocampus regions compared to FH- and FHp subjects, independent of APOE4 status, gender, and age. Individuals with an ε4 allele had more regional atrophy in the frontal cortex compared to ε4 noncarriers. CONCLUSIONS: We conclude that FHm individuals without dementia have progressive gray matter volume reductions in select AD-vulnerable brain regions, specifically the precuneus and parahippocampal gyrus. These data complement and extend reports of regional cerebral metabolic differences and increases in amyloid-β burden in FHm subjects, which may be related to a higher risk for developing AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e31820e7b74

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cognitively intact children of AD mothers, relative to children of AD fathers, show greater age-associated brain atrophy, faster longitudinal brain atrophy, increased Aβ plaque deposition, elevated CSF oxidative stress markers, and AD-like CSF Aβ changes.

    “Subsequent studies found that the cognitively intact children of AD mothers, relative to the cognitively intact children of AD fathers, show greater degrees of age-associated brain atrophy, faster rates of longitudinal brain atrophy, increased Aβ plaque deposition, elevated cerebrospinal fluid (CSF) oxidative stress markers, and AD-like CSF Aβ changes [130-137].”
  • Maternal inheritance appears to determine several AD endophenotypes.

    “Maternal inheritance appears to determine several AD endophenotypes.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 41 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

  1. Burns JM, Donnelly JE, Anderson HS, et al. Peripheral insulin and brain structure in early Alzheimer disease. Neurology 2007;69:1094 -1104.
  2. Ashburner J, Andersson JL, Friston KJ. Image registration using a symmetric prior: in three dimensions. Hum Brain Mapp 2000;9:212-225.
  3. Chetelat G, Villemagne VL, Bourgeat P, et al. Relation- ship between atrophy and beta-amyloid deposition in Alz- heimer disease. Ann Neurol 2010;67:317-324.
  4. Duara R, Barker WW, Lopez-Alberola R, et al. Alzhei- mer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 1996;46:1575-1579.
  5. Neurology ® Launches Subspecialty Alerts by E-mail! Customize your online journal experience by signing up for e-mail alerts related to your subspecialty or area of interest. Access this free service by visiting http://www.neurology.org/cgi/alerts/ etoc.xhtml or click on the "E-mail Alerts" link on the home page. An extensive list of subspecialties, methods, and study design choices will be available for you to choose from-allowing you priority alerts to cutting-edge research in your field!

Cited by

Sorted by citations

Authors
Honea, R. A., Swerdlow, R. H., Vidoni, E. D., & Burns, J. M.
Affiliations
University of Kansas (US)
Venue
Neurology
Published
2011-03
Volume
76
Issue
9
Pages
822-829
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2011089487
Cited by
99
References
41
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 13 · 2013: 12 · 2012: 13
FWCI
9.91
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (R21AG029615, R03AG026374)
  • National Institute of Neurological Disorders and Stroke (K23NS058252)
  • National Center for Research Resources (M01RR023940)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
Keywords
Alzheimer's disease, family history (medicine), gray matter atrophy, maternal history, paternal history, precuneus, parahippocampal gyrus, hippocampus, APOE ε4, brain aging, cognitively normal elderly, voxel-based morphometry
MeSH terms
Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Atrophy, Cerebral Cortex, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mothers, Risk Factors, Disease Progression, Genetic Predisposition to Disease, Parahippocampal Gyrus, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review